Drug intelligence / Profile preview

lactulose + bisacodyl

Development stage
Phase 2
Lead developer
Mankind Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Lactulose + bisacodyl is a combination laxative therapy primarily used for the management of chronic constipation and for bowel preparation prior to diagnostic procedures such as colonoscopy. The combination utilizes two distinct mechanisms of action to facilitate bowel movements. Lactulose is a synthetic disaccharide that acts as an osmotic laxative; it is not absorbed in the small intestine and is fermented by colonic bacteria into organic acids (such as lactic and acetic acids), which increase osmotic pressure and acidify the colonic contents, thereby drawing water into the intestinal lumen. Bisacodyl is a stimulant laxative that acts directly on the colonic mucosa and the myenteric plexus to stimulate peristalsis and increase the secretion of water and electrolytes. This dual approach provides a synergistic effect, improving stool consistency and frequency more effectively than either agent alone in certain patient populations.

Brand names
Lactu-BisaLactu-BisLactu-Bisacodyl
Other names
lactulose and bisacodyl
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on lactulose + bisacodyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lactulose + bisacodyl.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call